These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25964492)

  • 21. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1.
    Podolin PL; Denny P; Lord CJ; Hill NJ; Todd JA; Peterson LB; Wicker LS; Lyons PA
    J Immunol; 1997 Aug; 159(4):1835-43. PubMed ID: 9257847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOD x 129.H2(g7) backcross delineates 129S1/SvImJ-derived genomic regions modulating type 1 diabetes development in mice.
    Leiter EH; Reifsnyder PC; Wallace R; Li R; King B; Churchill GC
    Diabetes; 2009 Jul; 58(7):1700-3. PubMed ID: 19336673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
    Bour-Jordan H; Thompson HL; Giampaolo JR; Davini D; Rosenthal W; Bluestone JA
    J Autoimmun; 2013 Sep; 45():58-67. PubMed ID: 23850635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10.
    Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Makino S; Sakamoto T; Ogihara T
    Biochem Biophys Res Commun; 2005 Jun; 331(2):536-42. PubMed ID: 15850792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizations of candidate genes for IDD susceptibility from the diabetes-prone NOD mouse strain.
    Chesnut K; She JX; Cheng I; Muralidharan K; Wakeland EK
    Mamm Genome; 1993; 4(10):549-54. PubMed ID: 8268651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes.
    Wicker LS; Todd JA; Prins JB; Podolin PL; Renjilian RJ; Peterson LB
    J Exp Med; 1994 Nov; 180(5):1705-13. PubMed ID: 7964456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
    Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains.
    Rogner UC; Boitard C; Morin J; Melanitou E; Avner P
    Genomics; 2001 Jun; 74(2):163-71. PubMed ID: 11386752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.
    Irie J; Wu Y; Sass DA; Ridgway WM
    Immunogenetics; 2006 Feb; 58(1):9-14. PubMed ID: 16425035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Truncated pStat5B is associated with the Idd4 locus in NOD mice.
    Davoodi-Semiromi A; McDuffie M; Litherland S; Clare-Salzler M
    Biochem Biophys Res Commun; 2007 May; 356(3):655-61. PubMed ID: 17382905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice.
    Reifsnyder PC; Li R; Silveira PA; Churchill G; Serreze DV; Leiter EH
    Genes Immun; 2005 Sep; 6(6):528-38. PubMed ID: 16015371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenic mice reveal genetic epistasis and overlapping disease loci for autoimmune diabetes and listeriosis.
    Wang N; Elso CM; Mackin L; Mannering SI; Strugnell RA; Wijburg OL; Brodnicki TC
    Immunogenetics; 2014 Aug; 66(7-8):501-6. PubMed ID: 24906421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice.
    Inoue K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Makimo S; Ogihara T
    Diabetologia; 2004 Apr; 47(4):739-47. PubMed ID: 15298352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasomes and human autoimmunity: A comprehensive review.
    Yang CA; Chiang BL
    J Autoimmun; 2015 Jul; 61():1-8. PubMed ID: 26005048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.
    McDuffie M; Maybee NA; Keller SR; Stevens BK; Garmey JC; Morris MA; Kropf E; Rival C; Ma K; Carter JD; Tersey SA; Nunemaker CS; Nadler JL
    Diabetes; 2008 Jan; 57(1):199-208. PubMed ID: 17940120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polygenic control of autoimmune diabetes in nonobese diabetic mice.
    Ghosh S; Palmer SM; Rodrigues NR; Cordell HJ; Hearne CM; Cornall RJ; Prins JB; McShane P; Lathrop GM; Peterson LB
    Nat Genet; 1993 Aug; 4(4):404-9. PubMed ID: 8401590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus.
    Forsberg MH; Foda B; Serreze DV; Chen YG
    Sci Rep; 2019 Mar; 9(1):4316. PubMed ID: 30867509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice.
    Brodnicki TC; Quirk F; Morahan G
    Diabetes; 2003 Jan; 52(1):218-22. PubMed ID: 12502517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.
    Prochazka M; Serreze DV; Worthen SM; Leiter EH
    Diabetes; 1989 Nov; 38(11):1446-55. PubMed ID: 2576007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.